Axsome Therap

Forecast & Rating21 analysts currently cover Axsome Therap, with about 95.2% giving a positive rating — meaning they expect the stock to rise. The average price target is $285.42, about 30.8% upside from the current price of $218.20. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 48.7% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Axsome Therap closely still see room for the stock to rise. Data as of Aug 18, 2026; for reference only and not investment advice.